Aug 2
|
Results: MiMedx Group, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
|
Aug 1
|
High Growth US Tech Stocks To Watch In August 2025
|
Jul 31
|
MiMedx Group Inc (MDXG) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ...
|
Jul 30
|
MiMedx (MDXG) Q2 Earnings and Revenues Beat Estimates
|
Jul 30
|
MIMEDX Announces Record Second Quarter 2025 Operating and Financial Results
|
Jul 30
|
MIMEDX Announces Strategic Collaboration with Vaporox, Inc.
|
Jul 16
|
Northland sees ‘key positive’ for MiMedx in CMS rule proposal
|
Jul 16
|
MIMEDX to Host Second Quarter 2025 Operating and Financial Results Conference Call on July 30
|
Jul 15
|
Sector Update: Health Care Stocks Fall Late Afternoon
|
Jul 15
|
MiMedx, Organogenesis Shares Fall After CMS Proposal to Cut Spending on Skin Substitute Products
|
Jul 15
|
MIMEDX Comments on Proposed Medicare Reimbursement Rule Changes for CY 2026
|
Jul 15
|
MiMedx Group (NASDAQ:MDXG) shareholders have earned a 27% CAGR over the last three years
|
Jul 14
|
MiMedx and Organogenesis stocks tumble after CMS proposal to slash spending
|
May 7
|
MiMedx Group's (NASDAQ:MDXG) Conservative Accounting Might Explain Soft Earnings
|
May 6
|
MIMEDX to Present at the BofA Securities 2025 Healthcare Conference
|
May 5
|
MIMEDX Announces Publication of Health Economics Data in Mohs Micrographic Surgery (MMS)
|
Oct 1
|
MIMEDX Showcases Leading Allograft Portfolio and Its Latest Scientific and Clinical Evidence at SAWC Fall
|
Aug 29
|
MiMedx Group (NASDAQ:MDXG) shareholders have endured a 56% loss from investing in the stock three years ago
|
Aug 26
|
DEFENDANT FIGHTS BACK AGAINST MiMEDX "BLATANT INTIMIDATION" NON-COMPETE SUIT
|
Jul 31
|
MiMedx: Q2 Earnings Snapshot
|